Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
5 hedge funds and large institutions have $7.49M invested in Abeona Therapeutics Inc Warrant in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
53% less capital invested
Capital invested by funds: $15.9M → $7.49M (-$8.36M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$5.57M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.37K |
ABEOW Hedge Fund Activity: Q3 2018 in Review
5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q3 2018, worth a combined $7.49M — down 53% from $15.9M a quarter earlier.
Fund positioning in ABEOW was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Perceptive Advisors, cutting an estimated $5.57M.
- 5 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $7.49M of Abeona Therapeutics Inc Warrant stock for Q3 2018, down 53% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q3 2018 and 0 closed out.
- The largest Abeona Therapeutics Inc Warrant seller in Q3 2018 was Perceptive Advisors, an estimated $5.57M sold.
Based on aggregated 13F filings for Q3 2018.